These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37148982)

  • 1. Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.
    Joseph K; Balushi MA; Ghosh S; Stenson T; Abraham A; Elangovan A; Warkentin H; Paulson K; Tankel K; Usmani N; Severin D; Schiller D; Wong C; Mulder K; Doll C; King K; Nijjar T
    Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):434-445. PubMed ID: 37148982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient reported quality of life after helical IMRT based concurrent chemoradiation of locally advanced anal cancer.
    Joseph K; Vos LJ; Warkentin H; Paulson K; Polkosnik LA; Usmani N; Tankel K; Severin D; Nijjar T; Schiller D; Wong C; Ghosh S; Mulder K; Field C
    Radiother Oncol; 2016 Aug; 120(2):228-33. PubMed ID: 27406441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
    Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Definitive Chemoradiation on Quality-of-Life Changes for Patients With Anal Cancer: Long-term Results of a Prospective Study.
    Hosni A; Ringash J; Han K; Liu ZA; Brierley JD; Wong RKS; Dawson LA; Cummings BJ; Krzyzanowska MK; Chen EX; Hedley D; Knox JJ; Easson AM; Lindsay P; Craig T; Kim J
    Dis Colon Rectum; 2022 May; 65(5):642-653. PubMed ID: 35067501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes.
    Gilbert A; Drinkwater K; McParland L; Adams R; Glynne-Jones R; Harrison M; Hawkins MA; Sebag-Montefiore D; Gilbert DC; Muirhead R
    Eur J Cancer; 2020 Mar; 128():7-16. PubMed ID: 32109852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
    Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
    Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
    Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
    Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
    Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and tumor control after short split-course chemoradiation for anal canal carcinoma.
    Provencher S; Oehler C; Lavertu S; Jolicoeur M; Fortin B; Donath D
    Radiat Oncol; 2010 May; 5():41. PubMed ID: 20492729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial.
    Sclafani F; Peckitt C; Cunningham D; Tait D; Giralt J; Glimelius B; Keränen SR; Bateman A; Hickish T; Tabernero J; Thomas J; Brown G; Oates J; Chau I
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):303-12. PubMed ID: 26031368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy.
    Tribius S; Haladyn S; Hanken H; Busch CJ; Krüll A; Petersen C; Bergelt C
    Strahlenther Onkol; 2021 Mar; 197(3):219-230. PubMed ID: 33377992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiation in female patients with anal cancer: Patient-reported outcome of acute and chronic side effects.
    Koerber SA; Seither B; Slynko A; Haefner MF; Krug D; Liermann J; Adeberg S; Herfarth K; Debus J; Sterzing F
    Tumori; 2019 Apr; 105(2):174-180. PubMed ID: 30484384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review.
    Pan YB; Maeda Y; Wilson A; Glynne-Jones R; Vaizey CJ
    Acta Oncol; 2018 Nov; 57(11):1427-1437. PubMed ID: 30264638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of life of patients with locally advanced rectal cancer after neoadjuvant therapy and sphincter-preserving surgery].
    Shi WK; Li YH; Qiu XY; Xiao Y; Zhou JL; Wu B; Lin GL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Apr; 25(4):348-356. PubMed ID: 35461204
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term effects of neoadjuvant chemoradiotherapy followed by sphincter-preserving resection on anal sphincter function in relation to quality of life among locally advanced rectal cancer patients: a cross-sectional analysis.
    Ozgen Z; Ozden S; Atasoy BM; Ozyurt H; Gencosmanoglu R; Imeryuz N
    Radiat Oncol; 2015 Aug; 10():168. PubMed ID: 26264590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
    Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
    Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
    [No Abstract]   [Full Text] [Related]  

  • 18. Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification.
    Lips IM; van Gils CH; van der Heide UA; Kruger AE; van Vulpen M
    BJU Int; 2009 Mar; 103(6):762-7. PubMed ID: 18990145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT.
    Maggio A; Rancati T; Gatti M; Cante D; Avuzzi B; Bianconi C; Badenchini F; Farina B; Ferrari P; Giandini T; Girelli G; Landoni V; Magli A; Moretti E; Petrucci E; Salmoiraghi P; Sanguineti G; Villa E; Waskiewicz JM; Guarneri A; Valdagni R; Fiorino C; Cozzarini C
    Curr Oncol; 2024 Feb; 31(2):839-848. PubMed ID: 38392056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Reported Bowel and Urinary Function in Long-Term Survivors of Squamous Cell Carcinoma of the Anus Treated With Definitive Intensity Modulated Radiation Therapy And Concurrent Chemotherapy.
    De B; Corrigan KL; Rooney MK; Ludmir EB; Das P; Smith GL; Taniguchi CM; Minsky BD; Koay EJ; Koong A; Morris VK; Messick CA; You YN; Chang GJ; Westney OL; Nogueras Gonzalez GM; Holliday EB
    Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):78-88. PubMed ID: 35589011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.